AQST

Market-moving news on Aquestive Therapeutics (NASDAQ: AQST): filings, earnings, deals and other events, from REDFILED.

Aquestive's Anaphylm is a sublingual epinephrine film roughly the size of a postage stamp.

AQST

AQUESTIVE (AQST) Resubmits Anaphylm NDA to FDA After January Rejection

Aquestive Therapeutics has refiled its New Drug Application for Anaphylm sublingual epinephrine film after completing the human factors and PK studies the FDA demanded.

Aquestive's Anaphylm is a sublingual film roughly the size of a postage stamp.

AQST

AQUESTIVE (AQST) Resubmits Anaphylm NDA to FDA After January Rejection

Aquestive has refiled its application for the needle-free epinephrine film Anaphylm, backed by new human factors and pharmacokinetic data.